Laidlaw & Company is a popular full service brokerage and investment banking firm that offers its clients personalized investment advice and skillful execution. The company serves private and public institutions. High net worth individual investors also receive important services from the company.
Laidlaw & Company has earned the respect of many for providing wealth management and investment banking services to the United Kingdom and the United States. Some of the investment banking services from the company includes raising capital through the placement of equities with high net worth retail investors and organizations, acquisition and financing, placement of debt and the mezzanine capital with investors, arrangement of national exchange listings and initial public offerings.
The company has been successful in its projects since it was started. However, in December last year, Relmada Therapeutics, a clinical stage company announced that it had decided to file a law suit against the investment banking and Brokerage Company. Two principles of the company, James Ahern and Matthew Eitner were also involved in the lawsuit. The lawsuit was presented at the Nevada District Court.
Laidlaw and Company had served as the brokerage and investment banker for Relmada Therapeutics in the recent past. Relmada Therapeutics requested the brokerage company to help it in raising capital. This decision exposed some confidential information from Relmada Therapeutics. Several months later, Laidlaw announced that they had decided to take effective control over the clinical stage firm. This decision did not go well with the institution, and they decided to take the matter to court.
According to the management at Relmada Therapeutics, Laidlaw and its principles breached their contract when they leaked important and confidential information from the institution. According to them, this was breach of contract, and they are now demanding for monetary compensation from the brokerage firm. The court issued a restraining order against Laidlaw and its principles.
It isn’t all too common for a popular and successful hedge fund manager to jump shit and take a shot dealing in Contemporary art. The art world eats up and spits out buyers and sellers on a regular basis, and if you deal in the high end market, you could be one purchase away from wiping out all your savings. Adam Sender is definitely not the average art buyer or dealer, as a matter of fact, he is more widely known for the profitable hedge fund that he managed. This story is not any you have heard in recent years.
Adam Sender was making money for just about everyone who would listen. His hedge fund was very successful, and clients were enjoying the enormous growth by taking money off the table and investing some back for future growth. Adam was taking profits however and looking to try his hand at something that had a slightly bigger return. Anyone who has ever dealt in the art industry knows that this is an extremely risky business, you could lose everything with one poor decision. Sender was convinced he could make serious money and decided to try the waters. Check out this article by ArtNews on Adam Sender.
One thing that happened that changed the course of Sender’s life was he saw how expensive it was to buy masterpieces. Famous artists like Warhol were fetching millions of dollars pr painting, an investment that just screamed trouble. It could take decades to squeeze out a small profit here, something just didn’t appeal to Sender so he changed course. He was not going to be deterred by the high price of Contemporary art, so he began looking at some masterpieces by artists a little further down the ladder. These works were spectacular, just not mainstream like the well-known artists.
So Sender began investing in these lesser-known artists, realizing he could score beautiful pieces for $100,000 a piece in most cases, usually never more than $200,000. That left a huge amount of room for profit if the market were to go on a huge upward turn. Sender continued to search and buy these paintings, deciding in 2006 that he needed to confirm his theory and sell of a few of the pieces. Sender then auctioned 40 pieces and walked away with $20 million dollars, he knew he was on to something.
Since that sale, Sender has amassed a huge collection of great pieces by 139 artists, which stands at 400 total pieces. Now that the hedge fund has run its course, Sender is looking to get out of the art business too and have Sotheby’s sell off his collection over the next 18 months. Once completely sold, Sender is projected to walk away from the business with $70 million dollars.
Popstars, Beyonce and Jay Z are being sued for their song “Drunk in Love.” A Hungarian singer is making allegations they used her voice from her song, “Bajba, Bajba Pelem.” The current lawsuit is asking for monetary compensation for damages and to prevent anyone from listening to the song.
Listening to the song, it is difficult to find the part that was apparently stolen. The songs do not sound alike at all. Furthermore, the song from the Hungarian singer cannot be found online. It is often that other singers who are not famous, to argue famous songs are not original. Singers usually are not the ones to produce songs. Singers rely on producers and songwriters to create songs for them. Songs that turn out to be similar could be just mere coincidences. If a singer released a song that never got popular, how can they argue it got stolen. It is highly unlikely an American such as Christian Brode or any singer would be listening to a Hungarian singer’s music. If indeed Popstars, Beyonce and Jay Z used this woman’s vocals, then she should be compensated for it. In the scenario, it is just a coincidence, nothing should be done.
Welcome to WordPress. This is your first post. Edit or delete it, then start blogging!